PET-based treatment response evaluation in rectal cancer: Prediction and validation

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 871-876

  Janssen, Marco H M ^a   Öllers, Michel C ^a   Van Stiphout, Ruud G P M ^a   Riedl, Robert G ^b   Van Den Bogaard, Jørgen ^a   Buijsen, Jeroen ^a   Lambin, Philippe ^a   Lammering, Guido ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiotherapy; Locally advanced rectal cancer; Pathological response prediction; Sequential PET CT imaging; TRG

Indexed keywords

AREA UNDER THE CURVES; CHEMORADIOTHERAPY; CLINICAL OUTCOME; CUT-OFF VALUE; FLUORODEOXYGLUCOSE; PATHOLOGICAL RESPONSE; PREDICTIVE MODELS; RECEIVER OPERATING CHARACTERISTIC CURVES; RECTAL CANCER; RESPONSE PREDICTION MODEL; ROC CURVES; STANDARDIZED UPTAKE VALUES; SURGICAL INTERVENTIONS; TREATMENT RESPONSE; TRG; TUMOR REGRESSION GRADES;

COMPUTERIZED TOMOGRAPHY; DISEASES; FORECASTING; MATHEMATICAL MODELS; METABOLISM; POSITRON EMISSION TOMOGRAPHY; TUMORS;

PATIENT TREATMENT;

CAPECITABINE; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

CHEMORADIOTHERAPY; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 80051786661     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.038     Document Type: Article

References (28)

1. C. Capirci, L. Rampin, and P.A. Erba Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy Eur J Nucl Med Mol Imaging 34 2007 1583 1593
2. C. Capirci, D. Rubello, and F. Chierichetti Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy AJR Am J Roentgenol 187 2006 W202 208
3. R.F. Vliegen, R.G. Beets-Tan, and B. Vanhauten Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 184 2008 457 464
4. V. Kalff, C. Duong, and E.G. Drummond Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery J Nucl Med 47 2006 14 22
5. H. Amthauer, T. Denecke, and B. Rau Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology Eur J Nucl Med Mol Imaging 31 2004 811 819
6. T. Denecke, B. Rau, and K.T. Hoffmann Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol 15 2005 1658 1666
7. J.G. Guillem, H.G. Moore, and T. Akhurst Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining long-term outcomes of rectal cancer J Am Coll Surg 199 2004 1 7
8. G.B. Melton, W.C. Lavely, and H.A. Jacene Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy J Gastrointest Surg 11 2007 961 969 discussion 969
9. G.L. Cascini, A. Avallone, and P. Delrio 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer J Nucl Med 47 2006 1241 1248
10. R. Rosenberg, K. Herrmann, and R. Gertler The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT Int J Colorectal Dis 24 2009 191 200
11. E. Hindie, C. Hennequin, and J.L. Moretti Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: Prognostic value and possible role in patient management Eur J Nucl Med Mol Imaging 34 2007 1576 1582
12. M.H. Janssen, M.C. Ollers, and R.G. Riedl Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 2010 392 399
13. H. Young, R. Baum, and U. Cremerius Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 95 2010 203 208
14. L.F. de Geus-Oei, D. Vriens, and H.W. van Laarhoven Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: A systematic review J Nucl Med 50 Suppl 1 2009 43S 54S
15. S. Beaulieu, P. Kinahan, and J. Tseng SUV varies with time after injection in (18)F-FDG PET of breast cancer: Characterization and method to adjust for time differences J Nucl Med 44 2003 1044 1050
16. M. Ollers, G. Bosmans, and A. van Baardwijk The integration of PET-CT scans from different hospitals into radiotherapy treatment planning Radiother Oncol 87 2008 142 146
17. J.F. Daisne, M. Sibomana, and A. Bol Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms Radiother Oncol 69 2003 247 250
18. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686
19. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
20. F.M. Vecchio, V. Valentini, and B.D. Minsky The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760
21. A.A. Veenhof, E. Bloemena, and A.F. Engel The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer Int J Colorectal Dis 24 2009 1091 1096
22. A. Habr-Gama, R.O. Perez, and I. Proscurshim Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71 2008 1181 1188
23. C.M. Dolinsky, N.N. Mahmoud, and R. Mick Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer J Surg Oncol 96 2007 207 212
24. P.F. Kao, Y.H. Chou, and C.W. Lai Diffuse FDG uptake in acute prostatitis Clin Nucl Med 33 2008 308 310
25. J.W. Keyes Jr SUV: Standard uptake or silly useless value? J Nucl Med 36 1995 1836 1839
26. L.M. Hamberg, G.J. Hunter, and N.M. Alpert The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification? J Nucl Med 35 1994 1308 1312
27. R. Boellaard, M.J. O'Doherty, and W.A. Weber FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 Eur J Nucl Med Mol Imaging 2009
28. Janssen MH, Ollers MC, Stiphout RG, et al. Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer. Radiother Oncol.